Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to evaluate the effect of preventive intravenous infusion of half molar sodium lactate on the onset of hypertensive intracranial episodes in severe head trauma. The investigators hypothesize that preventive intravenous administration of sodium lactate will decrease the number of treatments required to decrease intracranial pressure during 48 hours.


Clinical Trial Description

- Intracranial hypertension is the most severe complication of severe head injury. This may lead to cerebral death or severe neurological outcome. To improve the prognosis of these patients,intracranial pressure must be maintained in normal range while maintaining cerebral perfusion pressure. Among numerous strategies, osmotherapy is frequently proposed to decrease intracranial pressure, using mannitol or hypertonic saline. Recently, it has been found that hypertonic sodium lactate infusion is more efficient to decrease intracranial hypertension compared with an equivalent volemic and osmotic mannitol administration.Thus, we hypothesized that a preventive sodium lactate infusion in severe head trauma could decrease the number of intracranial hypertensive episodes.

- Methods and Objectives : to compare in a randomized double-blind fashion two group of patients, i.e., those receiving a standard isotonic saline infusion (control group) with those receiving half-molar sodium lactate for 48 hours following admission in ICU. The primary endpoint is the number of any treatment required to control intracranial hypertensive episodes occurring during the first 48 hours following admission in ICU. Secondary endpoints are the effect of sodium lactate infusion on : intracranial pressure evolution;neurological outcome at 6 months (glasgow outcome scale); cerebral blood flow evaluated by transcranial doppler; and daily water balance

- Protocol consisted to measure as soon as possible baseline intracranial pressure and cerebral perfusion pressure, then immediately to begin the administration of 0.5 ml/kg/h intravenous isotonic saline perfusion or half-molar sodium lactate during 48 hours in a randomized double-blind fashion. Management of patients is the same for all patients. Treatment required for intracranial hypertensive episode is decided by a senior physician in charge of the patient. Sample size has been calculated considering that 50% of these patients will develop at least one intracranial hypertensive episode, each of them requiring at least 2 treatments. Based on previous results, we hypothesized that sodium lactate will decrease the number of required treatment by 2, leading to a sample size of 30 patients per group

- Follow up : 48 hours for treatments of intracranial hypertensive episodes; 6 months for the neurological outcome (glasgow outcome scale) ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00995683
Study type Interventional
Source Institut d'Anesthesiologie des Alpes Maritimes
Contact
Status Completed
Phase Phase 2/Phase 3
Start date June 2009
Completion date May 2011

See also
  Status Clinical Trial Phase
Completed NCT03291964 - Rapid MRI for Acute Pediatric Head Trauma
Completed NCT02828306 - Computer Based Algorithm for Patient Specific Implants for Cranioplasty in Patients With Skull Defects
Completed NCT04505293 - Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas N/A
Not yet recruiting NCT02232347 - Ketamine and Glutamate After Brain Injury : a Microdialysis Study Phase 2
Completed NCT01448473 - Is a Two-Film Skull X-ray Series as Sensitive as a Four-Film Series in the Diagnosis of Skull Fractures in Paediatric Patients N/A
Terminated NCT00847977 - Interest of Using Balanced Fluid for Infusion at the Early Phase of an Acute Cranial Trauma for Limiting Hyperchloremic Acidosis Phase 3
Completed NCT00622778 - Immunemodulation in Patients With Minor Head Injury N/A
Completed NCT04495634 - Evaluation of a Carbon Nanotube Enabled Solid-State Head CT N/A
Terminated NCT03680911 - NAC for Head Trauma-induced Anosmia Phase 3
Recruiting NCT06173427 - Monitoring of Intracranial Hemorrhage in Non-severe Head Trauma Patients Hospitalized in the UHCD
Completed NCT03742427 - Effect of Cervical Collar on the Optic Nerve Sheath Diameter in Minor Head Trauma N/A
Terminated NCT06246500 - Severe Head Trauma: Coagulation and CT-Scan Aggravation.
Withdrawn NCT03453749 - Anti-secretory Factor as a Treatment for Adults With Severe Traumatic Head Injury Phase 2
Not yet recruiting NCT05195606 - The Effect of Auditory and Tactile Stimuli in Traumatic Coma N/A
Completed NCT04020874 - Reducing Head Impact Exposure in Hawaii High School Football N/A
Not yet recruiting NCT06113939 - Prevention of Infection of the Respiratory Tract Through Application of Non-Invasive Methods of Secretion Suctioning N/A
Recruiting NCT05386966 - Medicolegal Aspects of Head Trauma
Not yet recruiting NCT03704272 - Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral N/A
Active, not recruiting NCT00196131 - Problems With Morphine Use in Patients With a Severe Brain Injury Phase 1/Phase 2
Withdrawn NCT02798601 - Early Induced Hypernatremia for the Prevention and Management of Brain Edema N/A